In this regard, EDCs can lead to the disruption of insulin production in the pancreatic beta cells and the peripheral insulin activity leading to T2DM and IR onset by disrupting the expression of insulin receptor substrate-1 and the activation of the protein kinase B-2 [34]. Here, INS is linked to type 2 diabetes mellitus.